1988
DOI: 10.1021/bi00401a011
|View full text |Cite
|
Sign up to set email alerts
|

Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG)

Abstract: Two sets of products are formed from DNA upon treatment with Fe(II).bleomycin + O2. One set, which is believed to derive from a C-4' hydroperoxy derivative of the DNA deoxyribose moiety, includes the four possible base propenals, as well as DNA oligomers having deoxynucleoside 3'-(phosphoro-2"-O-glycolates) at their 3'-termini. The other set of products consists of free bases and alkali-labile lesions, the latter of which had not previously been characterized structurally. By use of the self-complementary dode… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
70
0

Year Published

1989
1989
2000
2000

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(79 citation statements)
references
References 41 publications
9
70
0
Order By: Relevance
“…In earlier experiments, this mobility has been found to be characteristic of a DNA fragment with a 3'-phosphoglycolate end ("glycolate") resulting from 4' chemistry (5,16,17). To determine the extent of the putative 4' chemistry, the drug reaction products were treated with hydrazine, which is known to react with the 4'-hydroxylated abasic site generated by bleomycin (18,19) and NCS-Chrom (5,6,20) to form a 3'-pyridazine derivative ("pyridazine") with elimination of the DNA fragment with a 3'-phosphate end (Scheme I). The pyridazine derivative (dashed arrow) migrates more slowly than the fragment with the 3'-phosphate end (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…In earlier experiments, this mobility has been found to be characteristic of a DNA fragment with a 3'-phosphoglycolate end ("glycolate") resulting from 4' chemistry (5,16,17). To determine the extent of the putative 4' chemistry, the drug reaction products were treated with hydrazine, which is known to react with the 4'-hydroxylated abasic site generated by bleomycin (18,19) and NCS-Chrom (5,6,20) to form a 3'-pyridazine derivative ("pyridazine") with elimination of the DNA fragment with a 3'-phosphate end (Scheme I). The pyridazine derivative (dashed arrow) migrates more slowly than the fragment with the 3'-phosphate end (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…NCS was added to a final concentration of 10 nM to start the reaction, which was allowed to proceed for 1.5 h at 0 "C. This concentration of NCS is well below that which results in "one-hit" kinetics. To cleave abasic sites, and thus to express them as strand breaks, either hydrazine (1 M, pH 8), for 4'-hydroxylated abasic sites (Sugiyama et al, 1988;Kappen et al, 1991), or putrescine (1 M, pH 8), for all abasic sites (Lindahl & Andersson, 1972;, was added to a final concentration of 100 mM and the solution was incubated at room temperature or 37 OC, respectively, for 1 h. The topologic forms in 0.2 pg of drug-treated plasmid DNA were resolved on a 1% agarose gel. Densitometry of the negative images of the ethidium bromide-stained gel (LKB Ultrascan XL) showed linear variation of signal with DNA concentration over the DNA range studied (Dedon & Goldberg, 1990).…”
Section: Methodsmentioning
confidence: 99%
“…Cl'-hydrogen atom abstraction ultimately yields a putrescinecleavable 2'-deoxyribonolactone abasic site (Kappen & Goldberg, 1989), while C4'-chemistry partitions to form either a strand break with 3'-phosphoglycolate-and S-phosphateended fragments or a 4'-hydroxylated abasic site (Scheme I of Saito et al, 1989;Frank et al, 1991;Kappen et al, 1991). The latter lesion is cleaved by putrescine to form phosphate-ended fragments (Lindahl & Andersson, 1972; or by hydrazine to form a 3'-phosphopyridizine derivative (Sugiyama et al, 1988; 'Based on the proposal of Myers (1987). et al, 1991).…”
mentioning
confidence: 99%
“…After incubation for 30 min at 370C, samples were passed over CM-25 Sephadex minicolumns (6) to remove bleomycin, split into two or three aliquots, and incubated for 1 hr at 370C in the presence or absence of putrescine (20 mM) or endonuclease III (8 units/ ml), in the same buffer but with 1 mM 2-mercaptoethanol. In some experiments, an aliquot was treated with hydrazine (20 mM) for 1 hr at 220C (7).…”
mentioning
confidence: 99%